机译:平均血小板体积预测弥漫性大B细胞淋巴瘤患者的预后
Department of HematologyThe First Affiliated Hospital of Wenzhou Medical UniversityWenzhou Zhejiang;
Department of HematologyThe First Affiliated Hospital of Wenzhou Medical UniversityWenzhou Zhejiang;
Department of HematologyThe First Affiliated Hospital of Wenzhou Medical UniversityWenzhou Zhejiang;
Department of HematologyThe First Affiliated Hospital of Wenzhou Medical UniversityWenzhou Zhejiang;
Department of Hematology and OncologyTraditional Chinese Medical Hospital of ZhujiZhejiang China;
Department of HematologyThe First Affiliated Hospital of Wenzhou Medical UniversityWenzhou Zhejiang;
Department of HematologyThe First Affiliated Hospital of Wenzhou Medical UniversityWenzhou Zhejiang;
Department of HematologyThe First Affiliated Hospital of Wenzhou Medical UniversityWenzhou Zhejiang;
Department of HematologyThe First Affiliated Hospital of Wenzhou Medical UniversityWenzhou Zhejiang;
Department of HematologyThe First Affiliated Hospital of Wenzhou Medical UniversityWenzhou Zhejiang;
Department of HematologyThe First Affiliated Hospital of Wenzhou Medical UniversityWenzhou Zhejiang;
Department of HematologyThe First Affiliated Hospital of Wenzhou Medical UniversityWenzhou Zhejiang;
Department of HematologyThe First Affiliated Hospital of Wenzhou Medical UniversityWenzhou Zhejiang;
Department of HematologyThe First Affiliated Hospital of Wenzhou Medical UniversityWenzhou Zhejiang;
Department of ProsthodonticsSchool and Hospital of Stomatology Wenzhou Medical UniversityWenzhou;
diffuse large B‐cell lymphoma; mean platelet volume; prognosis; survival;
机译:平均血小板体积预测弥漫性大B细胞淋巴瘤患者的预后
机译:PET / CT中的高总代谢肿瘤体积预测弥漫性大B细胞淋巴瘤患者的较差的预后,骨髓患者在利妥昔单抗时代参与
机译:用于弥漫性大B细胞淋巴瘤的患者静脉血栓栓塞和死亡率的平均血小板体积作为预测标志物
机译:在犬弥漫性大B细胞淋巴瘤中,达斯3途径上调,并与预后差有关
机译:免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性:RU051417I-R-ICE(利妥昔单抗-异环磷酰胺-卡铂-依托泊苷)与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤(DLBCL)。
机译:血红蛋白和平均血小板体积预测镰状细胞病患者的弥漫性T1-MRI白质体积减少
机译:血小板计数和平均血小板体积(COP-MPV)的结合可预测可切除的早期和晚期食管鳞癌患者的术后预后